The biosecurity benefits of genetic engineering attribution.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
08 12 2020
Historique:
received: 09 03 2020
accepted: 28 09 2020
entrez: 9 12 2020
pubmed: 10 12 2020
medline: 8 1 2021
Statut: epublish

Résumé

Biology can be misused, and the risk of this causing widespread harm increases in step with the rapid march of technological progress. A key security challenge involves attribution: determining, in the wake of a human-caused biological event, who was responsible. Recent scientific developments have demonstrated a capability for detecting whether an organism involved in such an event has been genetically modified and, if modified, to infer from its genetic sequence its likely lab of origin. We believe this technique could be developed into powerful forensic tools to aid the attribution of outbreaks caused by genetically engineered pathogens, and thus protect against the potential misuse of synthetic biology.

Identifiants

pubmed: 33293537
doi: 10.1038/s41467-020-19149-2
pii: 10.1038/s41467-020-19149-2
pmc: PMC7722838
doi:

Substances chimiques

DNA 9007-49-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

6294

Références

Lancet. 2004 May 15;363(9421):1566-8
pubmed: 15145625
mBio. 2014 Dec 12;5(6):
pubmed: 25505122
mBio. 2015 Aug 18;6(4):
pubmed: 26286690
Nat Commun. 2018 Aug 7;9(1):3135
pubmed: 30087331

Auteurs

Gregory Lewis (G)

Future of Humanity Institute, Oxford University, Oxford, UK. gregory.lewis@zoo.ox.ac.uk.
Alt. Technology Labs, Inc., Berkeley, CA, USA. gregory.lewis@zoo.ox.ac.uk.

Jacob L Jordan (JL)

Nuclear Threat Initiative, Washington, DC, USA.

David A Relman (DA)

Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Department of Microbiology & Immunology, Stanford University School of Medicine; and Center for International Security and Cooperation, Stanford University, Stanford, CA, USA.

Gregory D Koblentz (GD)

Schar School of Policy and Government, George Mason University, Washington, DC, USA.

Jade Leung (J)

Future of Humanity Institute, Oxford University, Oxford, UK.

Allan Dafoe (A)

Future of Humanity Institute, Oxford University, Oxford, UK.

Cassidy Nelson (C)

Future of Humanity Institute, Oxford University, Oxford, UK.

Gerald L Epstein (GL)

Center for the Study of Weapons of Mass Destruction, National Defense University, Washington, DC, USA.

Rebecca Katz (R)

Center for Global Health Science and Security, Georgetown University, Washington, DC, USA.

Michael Montague (M)

Center for Health Security, Johns Hopkins University, Baltimore, MD, USA.

Ethan C Alley (EC)

Alt. Technology Labs, Inc., Berkeley, CA, USA.
Media Laboratory, Massachusetts Institute of Technology, Cambridge, MA, USA.
Department of Genetics, Harvard Medical School, Boston, MA, USA.

Claire Marie Filone (CM)

The Johns Hopkins University Applied Physics Laboratory, Laurel, MA, USA.

Stephen Luby (S)

Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.

George M Church (GM)

Alt. Technology Labs, Inc., Berkeley, CA, USA.
Department of Genetics, Harvard Medical School, Boston, MA, USA.

Piers Millett (P)

Future of Humanity Institute, Oxford University, Oxford, UK.
International Genetically Engineered Machine Competition, Boston, MA, USA.

Kevin M Esvelt (KM)

Alt. Technology Labs, Inc., Berkeley, CA, USA.
Media Laboratory, Massachusetts Institute of Technology, Cambridge, MA, USA.

Elizabeth E Cameron (EE)

Nuclear Threat Initiative, Washington, DC, USA.

Thomas V Inglesby (TV)

Center for Health Security, Johns Hopkins University, Baltimore, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH